BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12624626)

  • 1. No association between thrombosis and factor V gene polymorphisms in Chinese Han population.
    Yanqing H; Fangping C; Qinzhi X; Zaifu J; Guangping W; Xiaoxia Z; Xiaoqun P; Xiaobo
    Thromb Haemost; 2003 Mar; 89(3):446-51. PubMed ID: 12624626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.
    Mingozzi F; Legnani C; Lunghi B; Scanavini D; Castoldi E; Palareti G; Marchetti G; Bernardi F
    Thromb Haemost; 2003 Jun; 89(6):983-9. PubMed ID: 12783110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden mutation in one family of Chinese origin.
    Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
    Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk.
    Sharma A; Bhakuni T; Biswas A; Ranjan R; Kumar R; Kishore K; Mahapatra M; Jairajpuri MA; Saxena R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):596-600. PubMed ID: 26699866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of activated protein C resistance, factor V coagulation activity and gene polymorphisms in patients with venous thromboembolism].
    Han XM; Ren JF; Hao B; Cao WD; Liu XE; Hou LH; Guo ZP; Yu B; Wang XF; Ding QL; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):612-6. PubMed ID: 17605877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.
    Sedano-Balbás S; Lyons M; Cleary B; Murray M; Gaffney G; Maher M
    BMC Pregnancy Childbirth; 2010 Mar; 10():11. PubMed ID: 20214832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel variants in the coagulation factor V gene associated with deep venous thrombosis in Chilean patients with Amerindian ethnic background.
    Guzmán N; Larama G; Ávila A; Salazar LA
    Clin Chim Acta; 2015 Apr; 444():24-8. PubMed ID: 25668227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.
    Adeyemo TA; Adediran A; Akinbami AA; Akanmu AS
    Niger J Clin Pract; 2012; 15(2):136-41. PubMed ID: 22718159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Val/Leu247 polymorphism of β2-glycoprotein I and thrombosis in Chinese patients with SLE.
    Liang W; Zhou J; Zhou S; Wang T; Yang L; Xu D; Deng G; Huang D; Mei C; He Y; Zhang Z
    Int J Lab Hematol; 2015 Feb; 37(1):22-8. PubMed ID: 24661363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.